Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer

A clinical validation of the bone scan lesion area (BSLA) as a quantitative imaging biomarker was performed in metastatic castration-resistant prostate cancer (mCRPC). BSLA was computed from whole-body bone scintigraphy at baseline and week 12 posttreatment in a cohort of 198 mCRPC subjects (127 tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Matthew S., Kim, Grace Hyun J., Chu, Gregory H., Ramakrishna, Bharath, Allen-Auerbach, Martin, Fischer, Cheryce P., Levine, Benjamin, Gupta, Pawan K., Schiepers, Christiaan W., Goldin, Jonathan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Photo-Optical Instrumentation Engineers 2018
Materias:
Quantitative Imaging Methods and Translational Developments–Honoring the Memory of Dr. Larry Clarke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764115/
https://www.ncbi.nlm.nih.gov/pubmed/29340285
http://dx.doi.org/10.1117/1.JMI.5.1.011017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764115/
https://www.ncbi.nlm.nih.gov/pubmed/29340285
http://dx.doi.org/10.1117/1.JMI.5.1.011017

Ejemplares similares